EXPLAINER: What's up between Google, Facebook and Australia? There are currently no items in this Watchlist. The average price target is $6.312, which means analysts expect the stock to increase by 164.10% over the next twelve months. To see all exchange delays and terms of use please see disclaimer. Please log in to your account or sign up in order to add this asset to your watchlist. VYNE Therapeutics Inc. (NASDAQ:VYNE)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.09. See what's happening in the market right now with MarketBeat's real-time news feed. Fundamental company data provided by Zacks Investment Research. The extremes give us $3 and $10 for target low and target high price respectively. Historical and current end-of-day data provided by FACTSET. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. During the day the stock fluctuated 8.53% from a … 7 Wall Street analysts have issued ratings and price targets for VYNE Therapeutics in the last 12 months. Analysts on Wall Street suggest a consensus price target of $5.93, implying an increase of 173.27% to the stock’s recent value. Intraday data delayed at least 15 minutes or per exchange requirements. VYNE updated stock price target summary. Have Watchlists? Start Your Risk-Free Trial Subscription Here, Stocks fall as investors fret over jobless claims, inflation, Walmart sales still surging, but a chill may be on the way. VYNE Therapeutics Inc. (VYNE… Applied Materials stock price target raised to $140 from $125 at Deutsche Bank, Roku stock price target raised to $500 from $400 at Deutsche Bank, Marriott stock price target raised to $135 from $96 at Deutsche Bank, Hyatt Hotels stock price target raised to $69 from $49 at Deutsche Bank, EHealth downgraded to hold from buy at Deutsche Bank, Scorpio Tankers downgraded to hold from buy at Deutsche Bank, Six Flags is hiring 'thousands' as it prepares to open all of its parks in 2021, Uber loses key legal fight, which could hurt its business model in the U.K. and hit gig-economy companies, Six Flags hiring 'thousands' of employees for 2021 season, Six Flags preparing to reopen every park for the 2021 season, VYNE will report 2020 earnings on 03/03/2022, VYNE will report Q4 2020 earnings on 05/12/2021. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Cookie Notice (). Last 30 Days Over the last 30 days this security got 1 buy, 0 sell and 0 hold … Their average twelve-month price target is $22.00, predicting that the stock has a possible upside of 157.61%. Do Not Sell My Information. VYNE Therapeutics's earnings in 2021 is -$253,885,000.On average, 3 Wall Street analysts forecast VYNE's earnings for 2021 to be $-77,691,062, with the lowest VYNE earnings foreca Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The Average True Range (ATR) for VYNE Therapeutics Inc. is set at 1.12, with the Price to Sales ratio for VYNE stock in the period of the last 12 months amounting to 102.78. Find the latest VYNE Therapeutics Inc. (VYNE) stock quote, history, news and other vital information to help you with your stock trading and investing. A high-level overview of VYNE Therapeutics Inc. (VYNE) stock. This browser is no longer supported at MarketWatch. Get (NYE | VYNE VYNE Therapeutics Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Get daily stock ideas top-performing Wall Street analysts. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 7 Wall Street analysts have issued twelve-month target prices for VYNE Therapeutics' stock. $5.50. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Copyright © 2021 MarketWatch, Inc. All rights reserved. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $5.50. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. The Price to Book ratio for the last quarter was 30.17, with the Price … The consensus price target of analysts on Wall Street is $5.93, which implies an increase of 118.82% to the stock’s current value. On Dec. 17, LifeSci Capital assigned a new Buy rating and $7.00 price target on VYNE. Average Target Price: 5.93: Number Of Ratings: 7: FY Report Date: 12/2020: Last Quarter's Earnings-0.13: Year Ago Earnings-2.99: Current Quarter's Estimate-0.13: Current Year's … Considering analysts have assigned the stock a price target range of $3-$10 as the low and high respectively, we find the trailing 12-month average consensus price target … MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. As such, VYNE has been trading 360.83% off suggested target … View our full suite of financial calendars and market data tables, all for free. The dark blue line represents the company's actual price. The stock has an average rating of “Buy” and an average price target of $4.88. The average price target is $5.50 … By using this site you agree to the According to analyst projections, VYNE’s forecast low is $12 with $40 as the target … The extremes of the forecast give a target low and a target … (106.77% Upside) Based on 3 analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. The consensus price target for the stock as assigned by Wall Street analysts is $22, meaning bulls need an upside of 117.39% from its current market value. The lighter blue line represents the stock's consensus price target. Maxim Group reissued a “positive” rating on shares of VYNE … Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The average price target represents a 245.91% upside from the last price … MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Want to see which stocks are moving? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Get short term trading ideas from the MarketBeat Idea Engine. Privacy Notice, and Currently, the analyst consensus on VYNE Therapeutics is a Strong Buy with an average price target of $7.50, which is a -28.7% downside from current levels. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The high price target for VYNE is $8.00 and the low price target for VYNE is $3.00. Benzinga - Mon, 05 … Log in to see them here or sign up to get started. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. That average ranki Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Analyst Price Target on VYNE. The word on The Street in general, suggests a Strong Buy analyst consensus rating for VYNE Therapeutics with a $7.88 average price target, representing a 337.8% upside. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Their average twelve-month price target is $5.50, predicting that the stock has a possible upside of 107.55%. Something went wrong while loading Watchlist. ... VYNE Therapeutics Inc. (VYNE) Performance Graph for POWR Ratings. Find real-time VYNE - Vyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The high price target for VYNE is $32.00 and the low price target for VYNE is $12.00. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. All quotes are in local exchange time. You can unlock it all now. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. For the best MarketWatch.com experience, please update to a modern browser. The average price target is $5.50, with a high forecast of $8.00 and a low forecast of $3.00. Find the latest VYNE Therapeutics Inc. (VYNE) stock quote, history, news and other vital information to help you with your stock trading and investing. Intraday Data provided by FACTSET and subject to terms of use. On average, analysts give VYNE a Strong Buy rating. $ 0.00 Based on analysts offering 12 month price targets for VYNE in the last 3 months. Top Stocks by Target Price Dividend Discount Model Stock Valuation ... We have 9 different ratings for every stock to help you appreciate its future potential. Stocks open lower on Wall Street, Treasury yields climb, Closing prices for crude oil, gold and other commodities, Texas crisis has governor facing big backer: energy industry, Perion Networks Stock Has More Upside From Here, Coty Stock Providing Pullback Opportunities, America’s Car-Mart (NASDAQ:CRMT) Sets New High As Business Accelerates, 6 Hot Cannabis Stocks For Penny Stock Investors, Bloomin' Brands Edges Out Expectations, Looks Forward to Future, 3 S&P 500 Laggards in 2020 Turned Leaders in 2021, Echo Park Drives Growth For Sonic Automotive Stock, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, Receive Analysts' Upgrades and Downgrades Daily. Average Price Target. … Export data to Excel for your own analysis. Learn everything you need to know about successful options trading with this three-part video course. All rights reserved. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Create a list of the investments you want to track. In a report issued on February 1, H.C. Wainwright also reiterated a Buy rating on the stock with a $3.50 price target. Notably, the analysts have cut their price target 7.2% to US$22.00, suggesting concerns around VYNE Therapeutics' valuation. On average, they anticipate VYNE Therapeutics' … Looking for new stock ideas? Several brokerages have weighed in on VYNE. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy.". Receive a free world-class investing education from MarketBeat. This price target is based on 7 analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Their forecasts range from $3.00 to $8.00. VYNE Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The price target was set to $3.00 - $3.50. View which stocks are hot on social media with MarketBeat's trending stocks report. © American Consumer News, LLC dba MarketBeat® 2010-2021. The average price target for VYNE is $6.312 and … VYNE Therapeutics Inc. (NASDAQ:VYNE)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.27. The average VYNE stock price target is 5.69 with a high estimate of 10.00 and a low estimate of 3.000. Identify stocks that meet your criteria using seven unique stock screeners. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Visit a quote page and your recently viewed tickers will be displayed here. InvestorsObserver is giving Vyne Therapeutics Inc (VYNE) an Analyst Rating Rank of 79, meaning VYNE is ranked higher by analysts than 79% of stocks. and has now fallen 4 days in a row. Subscriber Agreement & Terms of Use, HC Wainwright is very positive to VYNE and gave it "Buy" rating on October 05, 2020. ... bought 4,219,409 shares of VYNE Therapeutics stock in a transaction that occurred on Thursday, January … Learn about financial terms, types of investments, trading strategies and more. Considering analysts have assigned the stock a price target range of $3-$10 … VYNE - Vyne Therapeutics Inc Stock quote - CNNMoney.com Markets In a report … You can opt out at any time. Learn more. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. On November 6th, H.C. Wainwright reissued its Buy rating and $3.50 a share price target on the stock. Learn more. Price *Price Target Lowest: 3.50 Median: 3.50 Highest: 3.50 *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. VYNE Therapeutics shares are trading higher after HC Wainwright & Co maintained its Buy rating on the stock and raised its price target from $3 to $3.50 per share. The chart below shows how a company's share price and consensus price target have changed over time. The Vyne Therapeutics Inc stock price fell by -0.3759% on the last day (Friday, 12th Feb 2021) from $2.66 to $2.65. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Best Homemade Kombucha Flavors, Calculate Area Of Irregular Shape Using Perimeter, Womp Womp Meaning, Woodsong Chapter 7, David Faustino Age, Disney 1000 Piece Puzzle, Lsat Reading Comprehension Book, Samsung Top Load Washer Suspension Rods, Llc Phantom Unit, How Does Netflix Make Money, Mad Magazine Online,